SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-522402
Filing Date
2016-03-30
Accepted
2016-03-30 07:30:34
Documents
3
Period of Report
2016-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d152881d8k.htm 8-K 18241
2 EX-99.1 d152881dex991.htm EX-99.1 51885
3 GRAPHIC g152881ex99_1pg001.jpg GRAPHIC 7785
  Complete submission text file 0001193125-16-522402.txt   82334
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 161537011
SIC: 2834 Pharmaceutical Preparations